Press Room

CMTA-STAR Awards $354,826 for CMT Clinical Trial (Glenolden, PA, December 7, 2021) The Charcot-Marie-Tooth Association Strategy to Accelerate Research (CMTA-STAR) awarded Dr. Mary M. Reilly and her team at the UCL Queen Square Institute of ...

CMTA-STAR Awards Researcher $98,985 For CMT1A Project Using Dental Pulp Stem Cells (Glenolden, PA, November 4, 2021) The Charcot-Marie-Tooth Association Strategy to Accelerate Research (CMTA-STAR) awarded $98,985 to Esther Wolfs, MSc, PhD, at Hasselt University in ...

CMTA and Taysha Gene Therapies Announce Collaboration for CMT4A (Glenolden, PA, November 2, 2021) The Charcot-Marie-Tooth Association Strategy to Accelerate Research (CMTA-STAR) today announced a venture philanthropy grant to Taysha Gene Therapies (Nasdaq: TSHA), a patient-centric, ...

CMTA and Applied Therapeutics Announce Collaboration for CMT-SORD (Glenolden, PA, October 26, 2021) The Charcot–Marie–Tooth Association (CMTA), the largest philanthropic funder of CMT research worldwide, and Applied Therapeutics, a clinical-stage biopharmaceutical company developing a pipeline of ...

Taysha Gene Therapies Announces Sponsored Genetic Testing for Giant Axonal Neuropathy (GAN) in Partnership with GeneDx as well as a Collaboration with Hereditary Neuropathy Foundation and Charcot-Marie-Tooth Association Centers of Excellence to Increase Access to ...